Please login to the form below

Not currently logged in
Email:
Password:

Lundbeck promotes Jacob Tolstrup to VP business development

Has experience in US market – an area of “increasing strategic importance” for the Denmark-based pharma firm

Jacob Tolstrup - LundbeckLundbeck has promoted Jacob Tolstrup to VP business development.

He moves from his previous position as VP finance and administration at Lundbeck's American subsidiary, Lundbeck US, and in his new role, he will lead the development of Lundbeck's existing and future partnerships, as well as being responsible for finding growth opportunities in the licensing of new drugs and potential acquisitions.

It will be his most senior position at Lundbeck since joining the Denmark-based pharma company in 1999.

“Jacob has delivered strong results in a very professional manner for several years in various positions,” said Lundbeck's CEO Ulf Wiinberg. “He also has significant experience in business development from the US market, which is of increasing strategic importance to us.”

During his time at the company he has also served as VP investor relations and communications; divisional director, investor relations and communications; and financial analyst and planner.

He had previously spent one year working in the finance department of US pharmaceutical company Abbott Laboratories.

22nd March 2012

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Peter Jackson
Rethinking our approach to infectious disease preparedness
The importance of long-term strategic investment to prepare for the next threat that emerges...
New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....

Infographics